[1]韩旭萌,焦明丽,詹合琴.藤黄酸作用靶点及相关信号通路研究进展[J].新乡医学院学报,2020,37(7):696-700.[doi:10.7683/xxyxyxb.2020.07.023]
点击复制

藤黄酸作用靶点及相关信号通路研究进展
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
37
期数:
2020年7
页码:
696-700
栏目:
综述
出版日期:
2020-07-05

文章信息/Info

作者:
韩旭萌焦明丽詹合琴
(新乡医学院药学院,河南 新乡 453003)
关键词:
藤黄酸作用靶点信号通路研究进展
分类号:
R932
DOI:
10.7683/xxyxyxb.2020.07.023
文献标志码:
A
摘要:
天然化合物具有显著的生物活性和临床活性,可以对抗各种疾病,改善患者生活质量。在中国古代和东亚其他地区,藤黄被用来主治痈疽疔毒、跌打损伤、金疮肿痛、瘀血凝结。藤黄酸是自中药藤黄中提取的一种天然化合物,是藤黄的主要活性成分之一,在疾病预防和治疗中的作用机制包括抗癌、抗炎、抗氧化应激、抗菌抗病毒等。本文总结了藤黄酸的有效作用靶点以及调控不同细胞信号通路在疾病中的主要作用,以期揭示藤黄酸在疾病预防和治疗中的可能性,为其后续研究提供一定的理论依据。

参考文献/References:

[1] MA J,MA Y,LIU X,et al.Gambogic acid inhibits osteoclast formation and ovariectomy-induced osteoporosis by suppressing the JNK,p38 and Akt signalling pathways [J].Biochem J,2015,469 (3):399-408.
[2] KASHYAP D,MONDAL R,TULI H S,et al.Molecular targets of gambogic acid in cancer:recent trends and advancements [J].Tumour Biol,2016,37 (10):12915-12925.
[3] DUAN N,HOU A J,LUAN B,et al.Gambogic acid exerts cardioprotective effects in a rat model of acute myocardial infarction through inhibition of inflammation,iNOS and NF-κB/p38 pathway [J].Exp Ther Med,2018,15 (2):1742-1748.
[4] TANG W L,TANG W H,SZEITZ A,et al.Systemic study of solvent-assisted active loading of gambogic acid into liposomes and its formulation optimization for improved delivery [J].Biomaterials,2018,166:13-26.
[5] LIU N N,HUANG H B,XU L,et al.The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo [J].Toxicol Lett,2014,224 (3):333-340.
[6] WANG J,ZHAO Q,QI Q,et al.Gambogic acid-induced degradation of mutant p53 is mediated by proteasome and related to CHIP [J].J Cell Biochem,2011,112 (2):509-519.
[7] LI X F,LIU S T,HUANG H B,et al.Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo [J].Cell Rep,2013,3 (1):211-222.
[8] FELTH J,LESIAK-MIECZKOWSKA K,D′ARCY P,et al.Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome system [J].Invest New Drugs,2013,31 (3):587-598.
[9] SHI X P,CHEN X,LI X F,et al.Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation [J].Clin Cancer Res,2014,20 (1):151-163.
[10] SHI X P,LAN X Y,CHEN X,et al.Gambogic acid induces apoptosis in diffuse large B-cell lymphoma cells via inducing proteasome inhibition [J].Sci Rep,2015,5:9694.DOI:10.1038/srep09694.
[11] LIU S T,ZHAO C G,YANG C S,et al.Gambogic acid suppresses pressure overload cardiac hypertrophy in rats [J].Am J Cardiovasc Dis,2013,3 (4):227-238.
[12] ZHAO C G,LIU S T,YANG C S,et al.Gambogic acid moderates cardiac responses to chronic hypoxia likely by acting on the proteasome and NF-kappaB pathway [J].Am J Cardiovasc Dis,2013,3 (3):135-145.
[13] WANG X,CHEN W T.Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation,angiogenesis and metastasis [J].Anticancer Agents Med Chem,2012,12 (8):994-1000.
[14] ALUKSANASUWAN S,PEERAPEN P,PLUMWORASAWAT S,et al.Highly effective methods for expression/purification of recombinant human HSP90 and its four distinct (N-LR-M-C) domains [J].Anal Biochem,2020,590:113518.DOI:10.1016/j.ab.2019.113518.
[15] ZHANG L R,YI Y T,CHEN J J,et al.Gambogic acid inhibits Hsp90 and deregulates TNF-α/NF-κB in HeLa cells [J].Biochem Biophys Res Commun,2010,403 (3/4):282-287.
[16] DAVENPORT J,MANJARREZ J R,PETERSON L,et al.Gambogic acid,a natural product inhibitor of Hsp90 [J].J Nat Prod,2011,74 (5):1085-1092.
[17] YIM K H,PRINCE T L,QU S,et al.Gambogic acid identifies an isoform-specific druggable pocket in the middle domain of Hsp90beta [J].Proc Natl Acad Sci USA,2016,113 (33):E4801- E4809.
[18] JOHNSEN K B,BURKHART A,THOMSEN L B,et al.Targeting the transferrin receptor for brain drug delivery [J].Prog Neurobiol,2019,181:101665.DOI:10.1016/j.pneurobio.2019.101665.
[19] WANG J J,GENG Y Y,ZHANG Y P,et al.Bacterial magnetosomes loaded with doxorubicin and transferrin improve targeted therapy of hepatocellular carcinoma [J].Nanotheranostics,2019,3 (3):284-298.
[20] FU M P,HE Q,GUO Z L,et al.Therapeutic bispecific T-cell engager antibody targeting the transferrin receptor [J].Front Immunol,2019,10:1396.DOI:10.3389/fimmu.2019.01396.
[21] KASIBHATLA S,JESSEN K A,MALIARTCHOUK S,et al.A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid [J].Proc Natl Acad Sci USA,2005,102 (34):12095-12100.
[22] YANG Y,YANG L,YOU Q D,et al.Differential apoptotic induction of gambogic acid,a novel anticancer natural product,on hepatoma cells and normal hepatocytes [J].Cancer Lett,2007,256 (2):259-266.
[23] ZHU X L,ZHANG H M,LIN Y,et al.Mechanisms of gambogic acid-induced apoptosis in non-small cell lung cancer cells in relation to transferrin receptors [J].J Chemother,2009,21 (6):666-672.
[24] JIAN J L,YANG Q,HUANG X.Src regulates Tyr20 phosphorylation of transferrin receptor-1 and potentiates breast cancer cell survival [J].J Biol Chem,2011,286 (41):35708-35715.
[25] DEHSHAHRI A,ASHRAFIZADEH M,GHASEMIPOUR AFSHAR E,et al.Topoisomerase inhibitors:pharmacology and emerging nanoscale delivery systems [J].Pharmacol Res,2019,151:104551.DOI:10.1016/j.phrs.2019.104551.
[26] JUN K Y,KWON Y.Proposal of dual Inhibitor targeting ATPase domains of topoisomerase II and heat shock protein 90 [J].Biomol Ther (Seoul),2016,24 (5):453-468.
[27] QIN Y X,MENG L H,HU C X,et al.Gambogic acid inhibits the catalytic activity of human topoisomerase IIα by binding to its ATPase domain [J].Mol Cancer Ther,2007,6 (9):2429-2440.
[28] RODRIGUES-FERREIRA S,MOLINA A,NAHMIAS C.Microtubule-associated tumor suppressors as prognostic biomarkers in breast cancer [J].Breast Cancer Res Treat,2020,179(2):267-273.
[29] CHEN J,GU H Y,LU N,et al.Microtubule depolymerization and phosphorylation of c-Jun N-terminal kinase-1 and p38 were involved in gambogic acid induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells [J].Life Sci,2008,83 (3/4):103-109.
[30] BILGILI H,BIALAS A J,GORSKI P,et al.Telomere abnormalities in the pathobiology of idiopathic pulmonary fibrosis [J].J Clin Med,2019,8 (8):1232.
[31] CHEN X,TANG W J,SHI J B,et al.Therapeutic strategies for targeting telomerase in cancer [J].Med Res Rev,2020,40(2):532-585.
[32] GURUNG R L,LIM S N,LOW G K,et al.MST-312 alters telomere dynamics,gene expression profiles and growth in human breast cancer cells [J].J Nutrigenet Nutrigenomics,2014,7 (4/5/6):283-298.
[33] GANESAN K,XU B.Telomeres inhibitors from natural products and their anticancer potential [J].Int J Mol Sci,2017,19 (1):13.
[34] WU Z Q,GUO Q L,YOU Q D,et al.Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells [J].Biol Pharm Bull,2004,27 (11):1769-1774.
[35] YU J,GUO Q L,YOU Q D,et al.Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells [J].Cancer Chemother Pharmacol,2006,58 (4):434-443.
[36] ZHOU Y Q,LI W C,ZHANG X X,et al.Global profiling of cellular targets of gambogic acid by quantitative chemical proteomics [J].Chem Commun (Camb),2016,52 (97):14035-14038.
[37] YANG J,LI C L,DING L,et al.Gambogic acid deactivates cytosolic and mitochondrial thioredoxins by covalent binding to the functional domain [J].J Nat Prod,2012,75 (6):1108-1116.
[38] TIAN C P,SUN R,LIU K K,et al.Multiplexed thiol reactivity profiling for target discovery of electrophilic natural products [J].Cell Chem Biol,2017,24 (11):1416-1427.
[39] PANDEY M K,SUNG B,AHN K S,et al.Gambogic acid,a novel ligand for transferrin receptor,potentiates TNF-induced apoptosis through modulation of the nuclear factor-κB signaling pathway [J].Blood,2007,110 (10):3517-3525.
[40] GENG J,XIAO S Y,ZHENG Z H,et al.Gambogic acid protects from endotoxin shock by suppressing pro-inflammatory factors in vivo and in vitro [J].Inflamm Res,2013,62 (2):165-172.
[41] PALEMPALLI U D,GANDHI U,KALANTARI P,et al.Gambogic acid covalently modifies IkappaB kinase-β subunit to mediate suppression of lipopolysaccharide-induced activation of NF-κB in macrophages [J].Biochem J,2009,419 (2):401-409.
[42] ZHAO K,ZHANG S,SONG X M,et al.Gambogic acid suppresses cancer invasion and migration by inhibiting TGFβ1-induced epithelial-to-mesenchymal transition [J].Oncotarget,2017,8 (16):27120-27136.
[43] REN J,LI L X,WANG Y,et al.Gambogic acid induces heme oxygenase-1 through Nrf2 signaling pathway and inhibits NF-κB and MAPK activation to reduce inflammation in LPS-activated RAW264.7 cells [J].Biomed Pharmacother,2019,109:555-562.
[44] TANG Q S,LU M D,ZHOU H,et al.Gambogic acid inhibits the growth of ovarian cancer tumors by regulating p65 activity [J].Oncol Lett,2017,13 (1):384-388.
[45] CASCAO R,VIDAL B,RAQUEL H,et al.Potent anti-inflammatory and antiproliferative effects of gambogic acid in a rat model of antigen-induced arthritis[J].Mediators Inflamm,2014,2014:195327.DOI:10.1155/2014/195327.
[46] WEN J L,PEI H Y,WANG X H,et al.Gambogic acid exhibits anti-psoriatic efficacy through inhibition of angiogenesis and inflammation [J].J Dermatol Sci,2014,74 (3):242-250.
[47] LI N,ZHOU H,TANG Q.miR-133:a suppressor of cardiac remodeling[J].Front Pharmacol,2018,9:903.DOI:10.3389/fphar.2018.00903.
[48] LAI H C,CHANG Q Y,HSIEH C L.Signal transduction pathways of acupuncture for treating some nervous system diseases [J].Evid Based Complement Alternat Med,2019,2019:2909632.DOI:10.1155/2019/2909632.
[49] CAO J,WANG J S,REN X H,et al.Spinal sample showing p-JNK and p38 associated with the pain signaling transduction of glial cell in neuropathic pain [J].Spinal Cord,2015,53 (2):92-97.
[50] FU Q,LI C J,YU L H.Gambogic acid inhibits spinal cord injury and inflammation through suppressing the p38 and Akt signaling pathways [J].Mol Med Rep,2018,17 (1):2026-2032.
[51] MA J,HUANG K,MA Y,et al.Gambogic acid inhibits LPS-induced macrophage pro-inflammatory cytokine production mainly through suppression of the p38 pathway [J].Iran J Basic Med Sci,2018,21 (7):717-723.
[52] PAN H,LU L Y,WANG X Q,et al.Gambogic acid Induces cell apoptosis and inhibits MAPK pathway in PTEN-/-/p53-/- prostate cancer cells in vitro and ex vivo [J].Chin J Integr Med,2018,24 (2):109-116.
[53] XU L F,LAO Y Z,ZHAO Y H,et al.Screening active compounds from garcinia species native to china reveals novel compounds targeting the STAT/JAK signaling pathway [J].Biomed Res Int,2015,2015:910453.DOI:10.1155/2015/910453.
[54] PRASAD S,PANDEY M K,YADAY V R,et al.Gambogic acid inhibits STAT3 phosphorylation through activation of protein tyrosine phosphatase SHP-1:potential role in proliferation and apoptosis [J].Cancer Prev Res (Phila),2011,4 (7):1084-1094.
[55] WAN L,ZHANG Q,WANG S,et al.Gambogic acid impairs tumor angiogenesis by targeting YAP/STAT3 signaling axis [J].Phytother Res,2019,33 (5):1579-1591.
[56] AOYAGI T,MATSUI T.Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure [J].Curr Pharm Des,2011,17 (18):1818-1824.
[57] CHEN H,ZHOU L,WU X,et al.The PI3K/AKT pathway in the pathogenesis of prostate cancer [J].Front Biosci (Landmark Ed),2016,21:1084-1091.
[58] LU L,TANG D,WANG L,et al.Gambogic acid inhibits TNF-α-induced invasion of human prostate cancer PC3 cells in vitro through PI3K/Akt and NF-κB signaling pathways [J].Acta Pharmacol Sin,2012,33 (4):531-541.
[59] WANG F,ZHANG W,GUO L T,et al.Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells [J].Cancer Sci,2014,105 (8):1063-1070.
[60] ZHOU Z L,MA J.Gambogic acid suppresses colon cancer cell activity in vitro [J].Exp Ther Med,2019,18 (4):2917-2923.
[61] YANG Y,SUN X D,YANG Y H,et al.Gambogic acid enhances the radiosensitivity of human esophageal cancer cells by inducing reactive oxygen species via targeting Akt/mTOR pathway [J].Tumour Biol,2016,37 (2):1853-1862.
[62] CUI J Y,GONG R,HU S Q,et al.Gambogic acid ameliorates diabetes-induced proliferative retinopathy through inhibition of the HIF-1α/VEGF expression via targeting PI3K/AKT pathway [J].Life Sci,2018,192:293-303.
[63] CASCAO R,VIDAL B,RAQUEL H,et al.Potent anti-inflammatory and antiproliferative effects of gambogic acid in a rat model of antigen-induced arthritis [J].Mediators Inflamm,2014,2014:195327.DOI:10.1155/2014/195327.
[64] WANG Q L,YANG D Z,LYU C X.Anti-inflammatory effects of gambogic acid in murine collagen-induced arthritis through PI3K/Akt signaling pathway [J].Mol Med Rep,2018,17 (3):4791-4796.
[65] LI G Q,ZHANG Y,LIU D,et al.PI3 kinase/Akt/HIF-1α pathway is associated with hypoxia-induced epithelial-mesenchymal transition in fibroblast-like synoviocytes of rheumatoid arthritis [J].Mol Cell Biochem,2013,372 (1/2):221-231.
[66] WU X D,LONG L,LIU J,et al.Gambogic acid suppresses inflammation in rheumatoid arthritis rats via PI3K/Akt/mTOR signaling pathway [J].Mol Med Rep,2017,16 (5):7112-7118.
[67] LIU Q,SHAN P,LI H.Gambogic acid prevents angiotensin II-induced abdominal aortic aneurysm through inflammatory and oxidative stress dependent targeting the PI3K/Akt/mTOR and NF-κB signaling pathways [J].Mol Med Rep,2019,19 (2):1396-1402.
[68] HE M Y,RO L,LIU J,et al.Folate-decorated arginine-based poly(ester urea urethane) nanoparticles as carriers for gambogic acid and effect on cancer cells [J].J Biomed Mater Res A,2017,105 (2):475-490.

更新日期/Last Update: 2020-07-05